| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $8,739,790 ) (Continued on the next page) |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA241845 | Validation of epigenomic biomarkers for thyroid cancer diagnostics | 000 | 5 | NIH | 12/10/2025 | $736,086 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156316 | Protein arginine methylation in transcription and RNA metabolism | 000 | 2 | NIH | 1/22/2026 | $400,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK134652 | Role of trefoil factor family proteins in beta cell function. | 000 | 4 | NIH | 12/5/2025 | $568,098 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK138665 | Targeting bile acid composition to treat metabolic diseases | 000 | 3 | NIH | 12/18/2025 | $665,898 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS132083 | Biological function and regulation of PRMT9 in synapse development | 000 | 3 | NIH | 1/23/2026 | $535,402 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279595 | Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia | 000 | 3 | NIH | 12/15/2025 | $637,252 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA286160 | Targeting Immune Escape in CML/MPN Transformation | 000 | 3 | NIH | 12/12/2025 | $514,454 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA283171 | Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation | 000 | 2 | NIH | 12/16/2025 | $632,001 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA297752 | Tumor-Selective Radiosensitization by Targeting Hypoxia in Rectal Cancer | 000 | 2 | NIH | 1/8/2026 | $578,672 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296394 | Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia | 000 | 2 | NIH | 12/10/2025 | $438,788 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296280 | CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHL | 000 | 2 | NIH | 12/10/2025 | $664,829 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 001 | 5 | NIH | 1/28/2026 | $556,363 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258778 | Targeting tumor-associated macrophages for triple-negative breast cancer treatment | 000 | 5 | NIH | 12/11/2025 | $467,633 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258981 | The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | 000 | 5 | NIH | 12/22/2025 | $488,601 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156498 | Emergent role of allostery on function of GPCRs and Trimeric G proteins | 001 | 2 | NIH | 1/22/2026 | $400,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | K23AI163343 | Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis | 001 | 7 | NIH | 1/26/2026 | $187,540 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA278050 | Mechanism and therapeutic opportunities of targeting the Tudor domain | 000 | 3 | NIH | 11/21/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA303874 | Dissecting the Functional Role of PAX5 Mutations in B-cell Acute Lymphoblastic Leukemia | 001 | 1 | NIH | 1/27/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA303874 | Dissecting the Functional Role of PAX5 Mutations in B-cell Acute Lymphoblastic Leukemia | 000 | 1 | NIH | 1/21/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA292596 | Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia | 000 | 1 | NIH | 1/29/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 000 | 4 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA261793 | Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer - Administrative Supplement | 000 | 4 | NIH | 11/25/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA259576 | The role of YTHDC1 in normal and malignant hematopoiesis | 001 | 5 | NIH | 2/10/2026 | $386,344 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA269569 | BAFF-R CAR T cell therapy for ALL | 000 | 4 | NIH | 1/28/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21CA282528 | Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer | 000 | 2 | NIH | 12/17/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 000 | 42 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 000 | 4 | NIH | 12/15/2025 | -$88,999 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U24CA247643 | PITT-CAL ETCTN PK Resource Laboratory | 000 | 6 | NIH | 12/19/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U19CA264512 | Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability | 001 | 5 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U19CA264512 | Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA264620 | Mechanism of estrogen independent proliferation in ER+ breast cancer cells | 001 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA264620 | Mechanism of estrogen independent proliferation in ER+ breast cancer cells | 000 | 5 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA214254 | Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer | 000 | 8 | NIH | 2/6/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA264620 | Mechanism of estrogen independent proliferation in ER+ breast cancer cells | 002 | 5 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156498 | Emergent role of allostery on function of GPCRs and Trimeric G proteins | 000 | 1 | NIH | 1/19/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 000 | 7 | NIH | 2/5/2026 | -$334,571 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R25CA275711 | Cancer Aging and Metabolism research experience Program (CAMP) | 000 | 2 | NIH | 12/3/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL156951 | Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling | 000 | 4 | NIH | 2/3/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01LM013876 | An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs | 000 | 4 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK143577 | Chromatin remodeling factors and mechanisms in diabetic microvascular complications | 000 | 1 | NIH | 12/22/2025 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266472 | Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer | 000 | 3 | NIH | 1/15/2026 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21CA293326 | A Blended e-Health Intervention for Fear of Progression in Advanced GYN Cancer | 000 | 1 | NIH | 1/28/2026 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 001 | 3 | NIH | 2/12/2026 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 001 | 3 | NIH | 2/12/2026 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 001 | 3 | NIH | 2/12/2026 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA286808 | A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment | 000 | 2 | NIH | 11/21/2025 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R56DK138666 | Conjugated bile acids as metabolic mediators between gut and fat tissues | 000 | 1 | NIH | 12/2/2025 | $0 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL124112 | Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | 001 | 11 | NIH | 2/10/2026 | $454,814 |
| | 2026 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R13ES036856 | Division of Chemical Toxicology Symposia at the 268th National ACS meeting | 000 | 1 | NIH | 11/24/2025 | -$285 |
|
